(Q54505454)
Statements
GSK-3 inhibition in vitro and in vivo enhances antitumor effect of sorafenib in renal cell carcinoma (RCC). (English)
Hisashi Kawazoe
Vladimir N Bilim
Andrey V Ugolkov
Kaori Yuuki
Sei Naito
Akira Nagaoka
Tomoyuki Kato
Yoshihiko Tomita
5 June 2012
423
3
490-495